The Ratings Game: Moderna’s stock suffering record losing streak as ‘investor caution remains high’ over COVID vaccine sales

Moderna’s stock was in danger of breaking its record for consecutive losses as investors expressed increasing caution over slowing sales of COVID vaccines.

Previous post Mark Hulbert: Will the real P/E ratio please stand up?
Next post Market Snapshot: Dow Jones looks for gains as 10-year Treasury yield pulls back from 5%